8 min listen
ACC CardiaCast: The Intersection of CVD and Type 2 Diabetes: The Role of SGLT2 Inhibitors and GLP-1 RAs in Cardiology
FromACC CardiaCast
ACC CardiaCast: The Intersection of CVD and Type 2 Diabetes: The Role of SGLT2 Inhibitors and GLP-1 RAs in Cardiology
FromACC CardiaCast
ratings:
Length:
11 minutes
Released:
May 18, 2020
Format:
Podcast episode
Description
In this episode, Christopher Granger is joined by endocrinologist Jennifer Green to discuss the role of GLP-1 receptor agonists and SGLT2 inhibitors in cardiology, what cardiologists need to know to use these drugs safely and effectively, and how important it is to understand their role in the use of these drugs
Released:
May 18, 2020
Format:
Podcast episode
Titles in the series (96)
ACC CardiaCast: Top 10 Things from the 2017 Expert Consensus Document: This podcast discusses the top 10 things you should remember from the ACC Focused Update on Non-Statin Therapies For LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: Expert Consensus Decision Pathway. by ACC CardiaCast